Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Q3 Revenues up Sharply

NEW YORK (GenomeWeb) – GeneNews today said that its revenues for the third quarter rose around 30-fold year over year.

The Toronto-based molecular diagnostics firm reported total revenues of C$1.1 million (US$973,000) for the three months ended Sept. 30, up from C$37,002 in Q3 2013, according to a regulatory document. All revenues for the recently completed quarter were derived from royalties. In the year-ago period, GeneNews had no royalties.

The firm said it had no milestone revenues for Q3 2014 compared to C$36,060 in the year-ago period, and no test revenues for the recently completed quarter, down from C$942 a year ago.

The company cut its net loss to C$893,407, or C$.02 per share, in Q3 2014, from a net loss of C$3.4 million, or C$.10 per share, a year ago.

GeneNews had no R&D costs for the third quarter, compared to C$490,720 a year ago. It trimmed its SG&A expenses 7 percent to C$933,751 from C$1.0 million.

The company exited the quarter with C$4.4 million in cash and cash equivalents.

During the summer of 2013, GeneNews, Health Diagnostic Laboratory, and an unnamed sales organization formed a joint venture called Innovative Diagnostic Laboratory. GeneNews said today that IDL had revenues of about C$4.7 million for the third quarter and costs of C$8.1 million, resulting in a loss of C$3.4 million.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.